|
H2AFZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.215700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.722200E-02 |
| Normal-vs-Stage2 |
1.504350E-02 |
| Normal-vs-Stage3 |
1.002370E-01 |
| Normal-vs-Stage4 |
1.246790E-01 |
| Stage1-vs-Stage2 |
4.511200E-01 |
| Stage1-vs-Stage3 |
3.259800E-01 |
| Stage1-vs-Stage4 |
5.158200E-01 |
| Stage2-vs-Stage3 |
2.101200E-01 |
| Stage2-vs-Stage4 |
3.024800E-01 |
| Stage3-vs-Stage4 |
8.884000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.448180E-02 |
| Normal-vs-AfricanAmerican |
2.578400E-01 |
| Normal-vs-Asian |
5.767600E-02 |
| Caucasian-vs-AfricanAmerican |
7.401000E-01 |
| Caucasian-vs-Asian |
8.869800E-01 |
| AfricanAmerican-vs-Asian |
6.750200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.146200E-02 |
| Normal-vs-Female |
2.534000E-02 |
| Male-vs-Female |
8.221400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.350110E-02 |
| Normal-vs-Age(41-60Yrs) |
1.032460E-02 |
| Normal-vs-Age(61-80Yrs) |
1.080050E-01 |
| Normal-vs-Age(81-100Yrs) |
3.718800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.653800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.879370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.283420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.441040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.232180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.897240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.897100E-03 |
| Classical-VS-Follicular |
1.615570E-02 |
| Classical-VS-Other |
5.647800E-01 |
| Classical-VS-Normal |
3.910200E-02 |
| Tall-VS-Follicular |
2.031200E-04 |
| Tall-VS-Other |
7.766200E-02 |
| Tall-VS-Normal |
7.162000E-01 |
| Follicular-VS-Other |
8.328600E-01 |
| Follicular-VS-Normal |
1.383390E-03 |
| Other-VS-Normal |
2.225600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.092200E-02 |
| Normal-vs-N1 |
1.616690E-03 |
| N0-vs-N1 |
5.771600E-02 |
|
|
